Standout Papers
Immediate Impact
3 from Science/Nature 125 standout
Citing Papers
NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation
2024 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Works of S Stoĭnov being referenced
Certolizumab Pegol for the Treatment of Crohn's Disease
2007 Standout
Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S Stoĭnov | 755 | 351 | 234 | 577 | 8 | 1.2k | |
| Juliet McColm | 693 | 167 | 187 | 540 | 11 | 1.3k | |
| Nathaniel Wisch | 751 | 147 | 309 | 503 | 24 | 1.2k | |
| Mark R. Fleisher | 662 | 106 | 215 | 511 | 17 | 1.2k | |
| Eric Vasiliauskas | 980 | 129 | 320 | 801 | 26 | 1.3k | |
| Anna Zholudev | 676 | 142 | 275 | 460 | 7 | 1.2k | |
| Charlotte Magdelaine–Beuzelin | 813 | 120 | 175 | 620 | 11 | 1.2k | |
| Michael J. Burt | 405 | 300 | 410 | 500 | 27 | 1.3k | |
| Deborah Woodworth | 1113 | 197 | 331 | 775 | 36 | 1.4k | |
| Paul Pollack | 1337 | 166 | 426 | 1067 | 29 | 1.7k | |
| Othmar Ludwiczek | 207 | 260 | 181 | 320 | 19 | 1.3k |
All Works
Loading papers...